CAPR
CAPRICOR THERAPEUTICS, INC.
+0.85 (+9.93%)9.41USD2.5M成交股數547M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-10下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | 2.3M-63% | 4.0M+1% | 4.9M | 12.1M | 6.2M | 3.9M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 28.9M | 27.4M | 23.1M | 20.4M | 22.0M | 18.9M | 11.8M | 12.5M | 11.1M | 9.9M | 10.0M | 8.8M |
| 銷售管理費用 | 14.1M | 9.4M | 6.0M | 5.9M | 5.7M | 6.1M | 3.5M | 3.1M | 4.1M | 3.4M | 3.0M | 2.8M |
| 營業利益 | −42.9M+55% | −36.8M+47% | −29.2M+124% | −26.3M+127% | −27.7M+170% | −25.0M+1850% | −13.0M+90% | −11.6M+50% | −10.3M | −1.3M | −6.9M | −7.7M |
| 營業利益率 | – | – | – | – | – | – | -575.2% | -291.9% | -209.2% | -10.6% | -111.0% | -197.8% |
| 稅後淨利 | −40.7M+57% | −33.9M+39% | −30.2M+140% | −24.6M+123% | −25.9M+165% | −24.4M+3101% | −12.6M+96% | −11.0M+49% | −9.8M | −762K | −6.4M | −7.4M |
| 淨利率 | – | – | – | – | – | – | -555.2% | -277.0% | -199.6% | -6.3% | -103.3% | -188.0% |
| 稀釋 EPS | -0.70+23% | -0.59+11% | -0.62+63% | -0.54+54% | -0.57+84% | -0.53-2750% | -0.38+52% | -0.35+21% | -0.31 | 0.02 | -0.25 | -0.29 |
| 稀釋股數 | 57.9M | 57.4M | 46.5M | 45.7M | 45.7M | 45.6M | 33.1M | 31.8M | 31.4M | 26.8M | 25.8M | 25.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 20.9M | 105M | 288M | 19.5M | 23.2M | 28.8M | 68.4M | 10.7M | 6.2M | 14.7M | 9.0M | 9.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 369M | 326M | 356M | 126M | 134M | 154M | 93.0M | 38.3M | 49.4M | 58.7M | 37.2M | 46.0M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 123M | 47.6M | 50.2M | 42.6M | 28.6M | 26.1M | 24.7M | 26.8M | 31.0M | 36.1M | 38.9M | 43.3M |
| 股東權益 | 246M | 279M | 306M | 83.9M | 105M | 128M | 68.3M | 11.5M | 18.4M | 22.6M | −1.8M | 2.7M |
| 負債比 | 33.2% | 14.6% | 14.1% | 33.7% | 21.4% | 17.0% | 26.6% | 70.0% | 62.7% | 61.5% | 104.8% | 94.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −29.3M+355% | – | – | – | −6.4M | – | – | −1.3M | – | – | – |
| 資本支出 | – | 5.1M | – | – | – | 896K | – | – | 609K | – | – | – |
| 自由現金流 | – | −34.4M+369% | – | – | – | −7.3M | – | – | −1.9M | – | – | – |
| 折舊攤銷 | – | 535K | – | – | – | 405K | – | – | 331K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -38.3% | – | – | – |
營收拆解 2024 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2024 年度 · 22.3M
| Single Reportable | 22.3M | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | -100.0% | −105M | –% | -2.26 | −72.7M |
| FY2024 | 22.3M | -11.5% | −40.5M | -181.7% | -1.15 | −41.2M |
| FY2023 | 25.2M | +886.8% | −22.3M | -88.5% | -0.83 | −26.9M |
| FY2022 | 2.6M | +941.8% | −29.0M | -1,137.4% | -1.18 | 2.9M |
| FY2021 | 245K | -21.1% | −20.0M | -8,175.9% | -0.87 | −18.0M |
| FY2020 | 310K | -69.1% | −13.7M | -4,401.9% | -0.88 | −10.6M |
| FY2019 | 1.0M | -39.9% | −7.6M | -760.4% | -2.06 | −6.8M |
| FY2018 | 1.7M | – | −15.2M | -908.9% | -0.52 | −14.2M |